DGX vs IVZ · P/E 22, rev $5.94B vs rev $3.57B
Quest Diagnostics Incorporated (DGX) versus Invesco Plc (IVZ) — a side-by-side from cached financials, not a winner call.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
Invesco Plc (IVZ) is a asset management company listed on NYSE.
Latest reported DGX revenue for 2026-06-30 was $5.94B. Net income was $572.0M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Latest reported IVZ revenue for 2026-06-30 was $3.57B. Net income was $558.0M. IVZ currently screens at market cap $12.76B.
DGX currently screens at market cap $19.94B and trailing P/E 22.4. IVZ currently screens at market cap $12.76B.
Not investment advice. Open the DGX and IVZ stock pages for the full models.
Not investment advice.